TECH DMA
As of date:2/6/2023
TECH stock price:75.57
TECH 50 DMA:82.28
TECH 200 DMA:84.48
TECH MACD (200-50):2.20

Also see:
TECH Market Cap History
TECH Shares Outstanding History
TECH YTD Return
TECH RSI
TECH MACD
TECH Technical Analysis

Trupanion (TRUP) Shares Cross Below 200 DMA
1 hour, 20 minutes ago


CHS Breaks Below 200-Day Moving Average - Notable for CHSCM
1 hour, 20 minutes ago


NUVA Makes Notable Cross Below Critical Moving Average
1 hour, 23 minutes ago


PRTS Crosses Below Key Moving Average Level
1 hour, 23 minutes ago


Mesa Laboratories (MLAB) Shares Cross Below 200 DMA
1 hour, 30 minutes ago


Notable Two Hundred Day Moving Average Cross - ENFN
1 hour, 36 minutes ago


BlackRock Municipal Target Term Trust Breaks Below 200-Day Moving Average - Notable for BTT
1 hour, 43 minutes ago


First Trust Dorsey Wright Dynamic Focus 5 (FVC) Shares Cross Below 200 DMA
1 hour, 43 minutes ago


FCTR Crosses Below Key Moving Average Level
1 hour, 56 minutes ago


Notable Two Hundred Day Moving Average Cross - AVY
1 hour, 56 minutes ago


Cohen & Steers Total Return Realty Fund (RFI) Shares Cross Below 200 DMA
1 hour, 56 minutes ago


Notable Two Hundred Day Moving Average Cross - VBND
2 hours ago


Loblaw Companies (L.CA) Shares Cross Above 200 DMA
2 hours, 4 minutes ago


Sonos Inc Breaks Below 200-Day Moving Average - Notable for SONO
4 hours, 28 minutes ago


The Trade Desk Breaks Below 200-Day Moving Average - Notable for TTD
4 hours, 30 minutes ago


More Technical Analysis News

TECH DMATECH MACD
Bio-Techne develops, manufactures and sells life science reagents, instruments and services for the research, diagnostics and bioprocessing markets. Co.'s Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics and cell and gene therapy. Co.'s Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications.

When researching a stock like Bio-Techne, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from TECH Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for TECH stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the TECH 200 day moving average ("TECH 200 DMA"), while one of the most popular "shorter look-backs" is the TECH 50 day moving average ("TECH 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Bio-Techne.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Quotes delayed 20 minutes

Email EnvelopeFree TECH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Bio-Techne (TECH) is categorized under the Healthcare sector; to help you further research DMA, below are some other companies in the same sector:

TFX DMA
TMO DMA
UHS DMA
VRTX DMA
VTRS DMA
WAT DMA
WST DMA
XRAY DMA
ZBH DMA
ZTS DMA
More Healthcare companies »

 

TECH DMA | www.StockDMA.com | Copyright © 2019 - 2023, All Rights Reserved

Nothing in StockDMA.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.